Redhill Biopharma 2.0 WKN: A40MF2 ISIN: US7574683014 Kürzel: RDHL Forum: Aktien User: ernesto62

Heute mal wieder zwischenzeitlich im Plus.

und der Kurs geh runter bei hohem Umsatz ! RedHill Biopharma Advances its Groundbreaking Late-Stage Crohn's Disease Program Building on Statistically Significant Positive RHB-104 Phase 3 Results---https://www.prnewswire.com/news-releases/redhill-biopharma-advances-its-groundbreaking-late-stage-crohns-disease-program-building-on-statistically-significant-positive-rhb-104-phase-3-results-302399719.html

Kein Ende in Sicht

weiter so ..., dann sind wir in 2 Wochen bei Null

Und heute nocheinmal. Puh...

Verrückt! 🔻

Was für ein Abgang 🤢

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties ---https://www.redhillbio.com/news/news-details/2025/RedHill-Licenses-RHB-102-for-Commercialization-Worldwide-Excluding-North-America-to-Hyloris-for-up-to-60-Million-in-Potential-Milestone-Payments-Plus-Royalties/default.aspx

https://www.marketscreener.com/quote/stock/HYLORIS-PHARMACEUTICALS-S-109048390/news/Hyloris-Pharmaceuticals-Broadens-Pipeline-with-RedHill-s-Ondansetron-Extended-Release-49147795/

es scheint doch was zu passieren: • Exclusive Licensing Agreement Signed with RedHill Biopharma for a Novel, Bimodal, Extended Release (’ER’) Formulation of the Antiemetic Drug Ondansetron ----https://live.euronext.com/en/products/equities/company-news/2025-02-25-hyloris-broadens-pipeline-redhills-ondansetron-extended

wusste gar nicht das die schon wieder Aktien verkaufen....das is doch nur noch beschiss RS kurs steigt dann wieder Aktien raushausen Kurs fällt...oh wir braucehn eine RS wegen delisting....so geht das die ganze zeit....ich nenne das Betrug

https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&ref=318884050&type=HTML&symbol=RDHL&cdn=25d971b3494e7b3be399ca3f7070176a&companyName=Redhill+Biopharma+Ltd.&formType=424B5&formDescription=Prospectus+%5BRule+424%28b%29%285%29%5D&dateFiled=2025-02-03

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

https://www.redhillbio.com/news/news-details/2025/RedHill-Announces-Initiation-of-Phase-2-Study-of-Opaganib-and-Darolutamide-in-Advanced-Prostate-Cancer/default.aspx

Grünenthal hätte dazumal Redhill kaufen und das ganze unfähige Management entlassen sollen. https://www.fiercepharma.com/pharma/grunenthal-continues-its-us-growth-push-250m-acquisition-valinor-pharma